Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -.--% | -99.07% |
01-17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.4M 1.39B |
---|---|---|---|---|---|
Net income 2022 | -40M -3.19B | Net income 2023 | -5M -399M | EV / Sales 2022 | - |
Net Debt 2022 | 351K 27.99M | Net Debt 2023 | 179K 14.28M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.06
x | P/E ratio 2023 |
-1.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.95% |
1 day | -96.36% | ||
1 month | -96.36% | ||
3 months | -96.36% | ||
6 months | -99.44% | ||
Current year | -99.07% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 08/09/22 |
Charles Allen
BRD | Director/Board Member | 49 | 04/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 08/09/22 |
Charles Allen
BRD | Director/Board Member | 49 | 04/12/22 |
Director/Board Member | 70 | 04/12/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | - | +-NaN% | 1 |
Delayed Quote OTC Markets, April 19, 2024 at 02:31 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+173.89% | 6.55B | |
+2.29% | 983M | |
+5.57% | 1.05B | |
+41.91% | 872M | |
+20.36% | 786M | |
+1.72% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+40.25% | 639M |
- Stock Market
- Equities
- IVBT Stock